Press Release Jan 23 2025
Filed with NSE · · 6 pages · English
Summary by 6ix AI
Mankind Pharma Ltd. has released its financial results for the third quarter of the fiscal year, highlighting a significant revenue increase compared to the previous year. The press release emphasizes the company's strong performance in the chronic and OTC segments, alongside the successful integration of BSV.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
In the deck
Earlier from Mankind Pharma
- Press Release Nov 05 2024
- Press Release Oct 23 2024
- Press Release Jul 31 2024
- Press Release Jul 25 2024
- Press Release May 15 2024
Later from Mankind Pharma
- Press Release May 21 2025
- Press Release Jul 31 2025
- Press Release Nov 06 2025
- Actimed Therapeutics Announces Important Licensing Agreement with Mankind Pharma
- Press Release Feb 03 2026
Follow Mankind Pharma into a list and get an email when it puts out news.
Follow Mankind Pharma